News Digest #200 – Biotech Revenue Reaches $370B, IndieBio’s New Class, Genomatica’s Bio-Nylon.

 

Hi all,

Rob Carlson just published a new Bioeconomy Dashboard, with revenue and technical metrics updated through 2016. Biotech revenues reached at least $370B in the U.S, up from $350 billion in 2012. Rob will be speaking at SynBioBeta 2018 – The Global Synthetic Biology Summit on October 1-3 in San Francisco which we just launched yesterday, you can register with the code “DIGEST” to save $50 before the early bird ends on January 31st. You will also be able to take part in over 100 “Synthetic Biology Week” satellite events that will be taking place throughout the Bay Area that week.


In IPO news, Synlogic, which is applying synthetic biology to probiotics to develop living medicines, announced a proposed public offering of common stock, and Intrexon announced the closing of its previously announced underwritten public offering of common stock. Amyris announced over $25 Million in grants.

LanzaTech signed a deal with TeselaGen to use its artificial intelligence platform to produce sustainable chemicals, Riffyn just opened a Boston office to meet accelerating demand for its own digital data platform for biological R&D, IndieBio announced their sixth class of startups, BioBright announced a collaboration with the Sanger Institute in the UK to cut drug-development time with more reproducible data, and Synpromics will work with UCL to develop gene therapies for blood-based disorders.

Some great new products hit the market or were announced this week as Butagaz and Global Bioenergies presented their first bottles containing bio-isobutene, a bio-sourced gas. Aquafil and Genomatica joined forces for bio-nylon, to make more sustainable nylon apparel, carpets and fibers. DuPont’s biomaterials business and a leading New Zealand wool producer will collaborate on more sustainable carpet yarns, and KnipBio achieved a key scale-up milestone in the production of aquaculture feed ingredients.


Genomatica’s process to make biobased nylon.

Finally, Modern Meadow announced the new hire of former Shinola exec Bridget Russo as CMO, and added former Michael Kors exec Anna Bakst to the board of directors. Modern Meadow’s CTO Dave Williamson spoke at SynBioBeta 2017 about the biofabrication company’s technology platform.

Have a great week,

Regards,
John

Who’s Hiring?

Product Scientist: Opentrons, New York


To feature your job here, please get in touch

News

Thought For Food Launches Its 2018 Global Challenge Calling on Youth to Tackle Food Security


Labcyte’s acoustic droplet ejection technology is miniaturizing high-throughput assembly


Students Invited to Design DNA Experiments for the International Space Station


Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer for the identification of novel antibodies


Ingenza to participate in the ConBioChem collaboration for the continuous bio-production of commodity chemicals


New England Biolabs Supports Creation of LabCentral Learning Lab


China, Unhampered by Rules, Races Ahead in Gene-Editing Trials (WSJ)


Microsoft is learning how to biologically search for images stored in DNA (MIT Technology Review)


Copyright © %%current_year_YYYY%%, All rights reserved.

SynBioBeta
1547 Palos Verdes Mall, #411
Walnut Creek, CA 94597

About Us | Update Preferences | Unsubscribe | View email in your browser

Stay updated on the latest news in synthetic biology

Join our weekly newsletter

Sign up

Add comment

Job opportunities

More